A survey of new Rx, new generic, and new OTC products
FDA Approves Lisocabtagene Maraleucel For Treatment of Relapsed or Refractory CLL, SLL
The approval was based on data from the phase 1/2 TRANSCEND CLL 004 study, in which the CAR T cell therapy demonstrated statistically significant complete response rates.
Looking to the Future of Independent Pharmacy
Don Arthur, RPh, discusses what lays ahead in independent pharmacy, from clinical care to success stories.
Breaking: FDA Approves Wegovy to Reduce Cardiovascular Risks in Overweight, Obesity
Study results demonstrated the efficacy of semaglutide (Wegovy) in reducing cardiovascular risks in adults with overweight or obesity without diabetes.
Podcast: Pharmacy Financing With First Financial Bank
Learn more about the ins and outs of pharmacy ownership from the experts at First Financial Bank.
FDA Grants Accelerated Approval to Zanubrutinib for R/R Follicular Lymphoma
This is the fifth oncology indication for zanubrutinib in the United States.
Breaking: FDA Clears Dexcom Stelo, First OTC Continuous Glucose Monitor
Dexcom's Stelo will be available in summer 2024.